ArticleEClinicalMedicine2026

Efficacy and safety of HRS-7535, an oral small-molecule GLP-1 receptor agonist, in patients with diabetic kidney disease (SOLID-DKD): a randomised, double-blind, placebo-controlled, phase 2 trial.

Rong Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.